Drug Pipeline
« Back to the pipeline
ZPL-389
ZPL-389
Company
Ziarco Pharma Ltd.
Therapeutic Approach
Oral Treatments
Indication
Psoriasis
Mechanism
anti-inflammatory (histamine H4 receptor antagonist)
Phase
Phase II
Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.